Literature DB >> 17596320

GLP-1 analogs: satiety without malaise?

Mads Tang-Christensen1, Michael A Cowley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17596320     DOI： 10.1152/ajpregu.00449.2007

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN： 0363-6119            Impact factor:   3.619


× No keyword cloud information.
  4 in total

Review 1.  GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Authors:  Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Exendin-4 decreases amphetamine-induced locomotor activity.

Authors:  Kevin Erreger; Adeola R Davis; Amanda M Poe; Nigel H Greig; Gregg D Stanwood; Aurelio Galli
Journal:  Physiol Behav       Date:  2012-03-19

3.  Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice.

Authors:  Takaya Yamamoto; Yukiomi Nakade; Taeko Yamauchi; Yuji Kobayashi; Norimitsu Ishii; Tomohiko Ohashi; Kiyoaki Ito; Ken Sato; Yoshitaka Fukuzawa; Masashi Yoneda
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

4.  Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.

Authors:  Yan Yang; Alexander A Moghadam; Zachary A Cordner; Nu-Chu Liang; Timothy H Moran
Journal:  Endocrinology       Date:  2014-06-20       Impact factor: 4.736
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.